- Home
- ZVRA vs NLOP Comparison
ZVRA vs NLOP Comparison
Compare ZVRA & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- NLOP
- Stock Information
- Founded
- ZVRA 2006
- NLOP N/A
- Country
- ZVRA United States
- NLOP United States
- Employees
- ZVRA N/A
- NLOP N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- ZVRA Health Care
- NLOP
- Exchange
- ZVRA Nasdaq
- NLOP Nasdaq
- Market Cap
- ZVRA 481.7M
- NLOP 474.6M
- IPO Year
- ZVRA 2015
- NLOP N/A
- Fundamental
- Price
- ZVRA $12.34
- NLOP $33.36
- Analyst Decision
- ZVRA Strong Buy
- NLOP Strong Buy
- Analyst Count
- ZVRA 9
- NLOP 1
- Target Price
- ZVRA $23.25
- NLOP $46.00
- AVG Volume (30 Days)
- ZVRA 1.0M
- NLOP 79.9K
- Earning Date
- ZVRA 08-12-2025
- NLOP 01-01-0001
- Dividend Yield
- ZVRA N/A
- NLOP 1.02%
- EPS Growth
- ZVRA N/A
- NLOP N/A
- EPS
- ZVRA N/A
- NLOP N/A
- Revenue
- ZVRA $40,588,000.00
- NLOP $127,453,000.00
- Revenue This Year
- ZVRA $292.31
- NLOP N/A
- Revenue Next Year
- ZVRA $78.65
- NLOP N/A
- P/E Ratio
- ZVRA N/A
- NLOP N/A
- Revenue Growth
- ZVRA 46.47
- NLOP N/A
- 52 Week Low
- ZVRA $5.45
- NLOP $23.38
- 52 Week High
- ZVRA $12.55
- NLOP $34.38
- Technical
- Relative Strength Index (RSI)
- ZVRA 84.06
- NLOP 52.40
- Support Level
- ZVRA $8.58
- NLOP $32.19
- Resistance Level
- ZVRA $12.37
- NLOP $33.01
- Average True Range (ATR)
- ZVRA 0.51
- NLOP 0.50
- MACD
- ZVRA 0.31
- NLOP -0.13
- Stochastic Oscillator
- ZVRA 98.47
- NLOP 14.94
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.